Authors: Hallscheidt, P Wallich, R Kauffmann, GW Pomer, S

Citation: P. Hallscheidt et al., Inhibition of TGF-beta and VEGF expression in human endothelium cell lineswith antisense-oligonucleotides: Potential tools for gene therapy of chronic renal transplant rejection, TRANSPLAN P, 33(3), 2001, pp. 2157-2159

Authors: Hallscheidt, P Pomer, S Roeren, T Kauffmann, GW Staehler, G

Citation: P. Hallscheidt et al., Preoperative staging of renal cell carcinoma with caval thrombus: is staging in MRI justified? Prospective histopathological correlated study, UROLOGE A, 39(1), 2000, pp. 36-40

Authors: Brauch, H Weirich, G Brieger, J Glavac, D Rodl, H Eichinger, M Feurer, M Weidt, E Puranakanitstha, C Neuhaus, C Pomer, S Brenner, W Schirmacher, P Storkel, S Rotter, M Masera, A Gugeler, N Decker, HJ

Citation: H. Brauch et al., VHL alterations in human clear cell renal cell carcinoma: Association withadvanced tumor stage and a novel hot spot mutation, CANCER RES, 60(7), 2000, pp. 1942-1948

Authors: Pitzer, C Schindowski, K Pomer, S Wirth, T Zoller, M

Citation: C. Pitzer et al., In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system, CANC GENE T, 6(2), 1999, pp. 139-146

Authors: Frank, MH Pomer, S

Citation: Mh. Frank et S. Pomer, Interferon alpha 2b differentially affects proliferation of two human renal cell carcinoma cell lines differing in the P-glycoprotein-associated multidrug-resistant phenotype, J CANC RES, 125(2), 1999, pp. 117-120